Health, with J&J a decalogue for restarting treatment after pandemic stop

From telemedicine as a necessary support to reduce the workload of hospitals, to their role as a reference for acute treatment, up to investments in digital health, intended as a source of data to improve therapeutic appropriateness and response to needs of patients, and in general as the pivot of the new system: they are the main items of the decalogue that the patient associations and scientific societies involved by Johnson & Johnson Medical Italia in the awareness campaign ‘My health cannot wait’, have drawn up to draw the lines guide the health system in post-Covid and promote the resumption of care. “The pandemic has highlighted the urgent need to redefine the concept of care around the needs of patients and the need to optimize the resources of the health system to improve standards of care – explained Silvia De Dominicis, CEO of J&J Medical Italia. – Together we have reflected on digital healthcare as an opportunity to imagine new health centers, including virtual ones, and as a starting point for leveraging data and artificial intelligence to ensure therapeutic appropriateness and equity of treatment “. , the decalogue also includes the “strengthening of the network, both virtual and on the territory, to manage chronicity, as well as the diagnostic and follow-up part”.